Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial
Chaganti, Sridhar, Maycock, Shanna, McIlroy, Graham, Jackson, Aimee E, Bishop, Rebecca, Johnson, Sarah, Kanfer, Edward, Kassam, Shireen, Cwynarski, Kate, Wrench, David J, Arumainathan, Arvind, Fox, Christopher P, Johnson, Rod J, McKay, Pamela, Paneesha, Shankara, Rowntree, Clare, Balotis, Constantine, Collins, Graham P, Davies, Andrew J, Wright, Josh, Burns, Dr, Sarah, Laurence, Arian Dominic John, Wheatley, Keith, Menne, Tobias
Published in Blood (21.04.2024)
Get full text
Published in Blood (21.04.2024)
Journal Article